Malaysia

Malaysia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.26 (1.14 - 1.38) 2019 Modelled IHME
1.32 (1.21 - 1.44) 2018 Modelled IHME
1.36 (1.23 - 1.50) 2017 Modelled IHME
1.37 (1.25 - 1.50) 2016 Modelled IHME
1.38 (1.25 - 1.52) 2015 Modelled IHME
1.39 (1.26 - 1.53) 2014 Modelled IHME
1.41 (1.28 - 1.54) 2013 Modelled IHME
1.43 (1.30 - 1.57) 2012 Modelled IHME
1.45 (1.33 - 1.61) 2011 Modelled IHME
1.47 (1.35 - 1.64) 2010 Modelled IHME
1.5 (1.37 - 1.65) 2009 Modelled IHME
1.52 (1.39 - 1.67) 2008 Modelled IHME
1.55 (1.41 - 1.70) 2007 Modelled IHME
1.58 (1.43 - 1.73) 2006 Modelled IHME
1.61 (1.45 - 1.77) 2005 Modelled IHME
1.63 (1.47 - 1.79) 2004 Modelled IHME
1.65 (1.49 - 1.81) 2003 Modelled IHME
1.67 (1.51 - 1.84) 2002 Modelled IHME
1.69 (1.53 - 1.86) 2001 Modelled IHME
1.71 (1.54 - 1.90) 2000 Modelled IHME
1.74 (1.57 - 1.93) 1999 Modelled IHME
1.77 (1.60 - 1.98) 1998 Modelled IHME
1.81 (1.62 - 2.01) 1997 Modelled IHME
1.84 (1.64 - 2.06) 1996 Modelled IHME
1.87 (1.66 - 2.11) 1995 Modelled IHME
1.9 (1.69 - 2.12) 1994 Modelled IHME
1.92 (1.71 - 2.14) 1993 Modelled IHME
1.95 (1.74 - 2.17) 1992 Modelled IHME
1.98 (1.75 - 2.20) 1991 Modelled IHME
2 (1.77 - 2.24) 1990 Modelled IHME
1.08 (0.79 - 1.52) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.09 (0.07 - 0.12) 2019 Modelled IHME
0.1 (0.07 - 0.12) 2018 Modelled IHME
0.1 (0.07 - 0.13) 2017 Modelled IHME
0.11 (0.08 - 0.13) 2016 Modelled IHME
0.11 (0.08 - 0.14) 2015 Modelled IHME
0.11 (0.08 - 0.14) 2014 Modelled IHME
0.11 (0.08 - 0.14) 2013 Modelled IHME
0.11 (0.08 - 0.14) 2012 Modelled IHME
0.11 (0.08 - 0.14) 2011 Modelled IHME
0.11 (0.08 - 0.14) 2010 Modelled IHME
0.11 (0.08 - 0.14) 2009 Modelled IHME
0.11 (0.08 - 0.14) 2008 Modelled IHME
0.11 (0.09 - 0.15) 2007 Modelled IHME
0.12 (0.09 - 0.15) 2006 Modelled IHME
0.12 (0.09 - 0.15) 2005 Modelled IHME
0.12 (0.09 - 0.16) 2004 Modelled IHME
0.13 (0.10 - 0.17) 2003 Modelled IHME
0.14 (0.11 - 0.18) 2002 Modelled IHME
0.16 (0.12 - 0.20) 2001 Modelled IHME
0.17 (0.13 - 0.22) 2000 Modelled IHME
0.19 (0.15 - 0.24) 1999 Modelled IHME
0.21 (0.16 - 0.27) 1998 Modelled IHME
0.24 (0.18 - 0.30) 1997 Modelled IHME
0.26 (0.20 - 0.33) 1996 Modelled IHME
0.29 (0.22 - 0.36) 1995 Modelled IHME
0.3 (0.23 - 0.38) 1994 Modelled IHME
0.32 (0.24 - 0.40) 1993 Modelled IHME
0.33 (0.26 - 0.42) 1992 Modelled IHME
0.35 (0.27 - 0.44) 1991 Modelled IHME
0.36 (0.28 - 0.45) 1990 Modelled IHME
0.17 (0.11 - 0.27) 2015 Modelled WHO
0.4 2009 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.59 (7.34 - 12.40) 2019 Modelled IHME
9.4 (7.41 - 11.90) 2018 Modelled IHME
9.27 (7.47 - 11.50) 2017 Modelled IHME
9.12 (7.50 - 10.90) 2016 Modelled IHME
8.93 (7.56 - 10.40) 2015 Modelled IHME
8.81 (7.62 - 10) 2014 Modelled IHME
8.59 (7.46 - 9.73) 2013 Modelled IHME
8.7 (7.56 - 9.81) 2012 Modelled IHME
8.71 (7.47 - 10) 2011 Modelled IHME
8.7 (7.50 - 9.94) 2010 Modelled IHME
8.74 (7.65 - 9.86) 2009 Modelled IHME
8.6 (7.55 - 9.66) 2008 Modelled IHME
8.39 (7.37 - 9.40) 2007 Modelled IHME
8.35 (7.35 - 9.38) 2006 Modelled IHME
8.27 (7.27 - 9.31) 2005 Modelled IHME
8.27 (7.27 - 9.29) 2004 Modelled IHME
8.24 (7.24 - 9.27) 2003 Modelled IHME
8.08 (7.06 - 9.09) 2002 Modelled IHME
8.05 (7.06 - 9.08) 2001 Modelled IHME
8.09 (7.07 - 9.16) 2000 Modelled IHME
8.45 (7.35 - 9.72) 1999 Modelled IHME
8.05 (7.02 - 9.15) 1998 Modelled IHME
8.3 (7.21 - 9.45) 1997 Modelled IHME
8.45 (7.34 - 9.58) 1996 Modelled IHME
8.5 (7.40 - 9.65) 1995 Modelled IHME
8.1 (7.03 - 9.16) 1994 Modelled IHME
7.76 (6.74 - 8.75) 1993 Modelled IHME
7.53 (6.55 - 8.50) 1992 Modelled IHME
7.32 (6.40 - 8.29) 1991 Modelled IHME
7.16 (6.28 - 8.10) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,001 (2,297 - 3,869) 2019 Modelled IHME
2,910 (2,292 - 3,682) 2018 Modelled IHME
2,836 (2,285 - 3,509) 2017 Modelled IHME
2,757 (2,268 - 3,310) 2016 Modelled IHME
2,670 (2,260 - 3,117) 2015 Modelled IHME
2,605 (2,254 - 2,964) 2014 Modelled IHME
2,509 (2,181 - 2,842) 2013 Modelled IHME
2,512 (2,182 - 2,832) 2012 Modelled IHME
2,483 (2,130 - 2,860) 2011 Modelled IHME
2,449 (2,111 - 2,798) 2010 Modelled IHME
2,428 (2,126 - 2,739) 2009 Modelled IHME
2,357 (2,070 - 2,647) 2008 Modelled IHME
2,268 (1,992 - 2,540) 2007 Modelled IHME
2,224 (1,958 - 2,499) 2006 Modelled IHME
2,170 (1,908 - 2,441) 2005 Modelled IHME
2,135 (1,877 - 2,398) 2004 Modelled IHME
2,090 (1,835 - 2,351) 2003 Modelled IHME
2,010 (1,758 - 2,261) 2002 Modelled IHME
1,963 (1,720 - 2,213) 2001 Modelled IHME
1,926 (1,684 - 2,182) 2000 Modelled IHME
1,963 (1,707 - 2,258) 1999 Modelled IHME
1,821 (1,588 - 2,069) 1998 Modelled IHME
1,824 (1,585 - 2,076) 1997 Modelled IHME
1,802 (1,565 - 2,045) 1996 Modelled IHME
1,759 (1,531 - 1,997) 1995 Modelled IHME
1,623 (1,408 - 1,835) 1994 Modelled IHME
1,506 (1,309 - 1,699) 1993 Modelled IHME
1,415 (1,231 - 1,598) 1992 Modelled IHME
1,333 (1,165 - 1,509) 1991 Modelled IHME
1,264 (1,108 - 1,430) 1990 Modelled IHME
2,604 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
57 (48 - 66) 2019 Modelled IHME
57 (48 - 65) 2018 Modelled IHME
57 (48 - 65) 2017 Modelled IHME
57 (48 - 65) 2016 Modelled IHME
57 (49 - 65) 2015 Modelled IHME
57 (49 - 66) 2014 Modelled IHME
57 (49 - 66) 2013 Modelled IHME
58 (50 - 66) 2012 Modelled IHME
58 (50 - 67) 2011 Modelled IHME
58 (50 - 67) 2010 Modelled IHME
58 (50 - 67) 2009 Modelled IHME
58 (50 - 66) 2008 Modelled IHME
58 (50 - 67) 2007 Modelled IHME
58 (50 - 67) 2006 Modelled IHME
59 (50 - 67) 2005 Modelled IHME
59 (50 - 67) 2004 Modelled IHME
58 (50 - 67) 2003 Modelled IHME
58 (50 - 66) 2002 Modelled IHME
58 (50 - 67) 2001 Modelled IHME
58 (50 - 67) 2000 Modelled IHME
59 (50 - 67) 1999 Modelled IHME
59 (51 - 67) 1998 Modelled IHME
59 (51 - 68) 1997 Modelled IHME
60 (51 - 68) 1996 Modelled IHME
59 (51 - 68) 1995 Modelled IHME
59 (51 - 67) 1994 Modelled IHME
60 (51 - 68) 1993 Modelled IHME
60 (51 - 68) 1992 Modelled IHME
60 (51 - 68) 1991 Modelled IHME
60 (51 - 68) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
88 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
90 2014 Survey/reported WHO/UNICEF
87 2013 Survey/reported WHO/UNICEF
91 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
95 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
90 2007 Survey/reported WHO/UNICEF
90 2006 Survey/reported WHO/UNICEF
90 2005 Survey/reported WHO/UNICEF
95 2004 Survey/reported WHO/UNICEF
90 2003 Survey/reported WHO/UNICEF
90 2002 Survey/reported WHO/UNICEF
97 2001 Survey/reported WHO/UNICEF
92 2000 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
96 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
96 2009 Survey/reported WHO/UNICEF
97 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
94 2004 Survey/reported WHO/UNICEF
95 2003 Survey/reported WHO/UNICEF
95 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
97 2000 Survey/reported WHO/UNICEF
96 1999 Survey/reported WHO/UNICEF
96 1998 Survey/reported WHO/UNICEF
97 1997 Survey/reported WHO/UNICEF
96 1996 Survey/reported WHO/UNICEF
96 1995 Survey/reported WHO/UNICEF
94 1994 Survey/reported WHO/UNICEF
86 1993 Survey/reported WHO/UNICEF
86 1992 Survey/reported WHO/UNICEF
89 1991 Survey/reported WHO/UNICEF
86 1990 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women, Risk-based
HepB birth dose policy
Yes
Year of birth dose introduction
1989
Eligible for HBV generic medicines
No
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.92 (1.54 - 2.37) 2019 Modelled IHME
1.91 (1.54 - 2.36) 2018 Modelled IHME
1.9 (1.53 - 2.36) 2017 Modelled IHME
1.88 (1.52 - 2.32) 2016 Modelled IHME
1.86 (1.48 - 2.30) 2015 Modelled IHME
1.91 (1.53 - 2.35) 2014 Modelled IHME
2.03 (1.63 - 2.49) 2013 Modelled IHME
2.17 (1.74 - 2.66) 2012 Modelled IHME
2.28 (1.83 - 2.81) 2011 Modelled IHME
2.33 (1.87 - 2.88) 2010 Modelled IHME
2.33 (1.86 - 2.85) 2009 Modelled IHME
2.31 (1.86 - 2.81) 2008 Modelled IHME
2.29 (1.86 - 2.78) 2007 Modelled IHME
2.28 (1.83 - 2.75) 2006 Modelled IHME
2.27 (1.82 - 2.75) 2005 Modelled IHME
2.28 (1.83 - 2.77) 2004 Modelled IHME
2.29 (1.85 - 2.80) 2003 Modelled IHME
2.31 (1.86 - 2.82) 2002 Modelled IHME
2.33 (1.88 - 2.85) 2001 Modelled IHME
2.33 (1.89 - 2.87) 2000 Modelled IHME
2.29 (1.85 - 2.81) 1999 Modelled IHME
2.18 (1.75 - 2.68) 1998 Modelled IHME
2.05 (1.64 - 2.52) 1997 Modelled IHME
1.95 (1.54 - 2.42) 1996 Modelled IHME
1.9 (1.49 - 2.36) 1995 Modelled IHME
1.9 (1.49 - 2.36) 1994 Modelled IHME
1.91 (1.51 - 2.37) 1993 Modelled IHME
1.94 (1.53 - 2.41) 1992 Modelled IHME
1.98 (1.56 - 2.48) 1991 Modelled IHME
2.05 (1.62 - 2.59) 1990 Modelled IHME
1.2 (0.80 - 1.30) 2015 Modelled Blach et al, 2017
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.5 (0.30 - 7.70) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
47.5 (17.70 - 79.20) 2019 Modelled Granados-Garcia V et al, 2019
67.1 (62.90 - 71.10) 2007 Survey/reported Vicknasingam B et al, 2009
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.44 (3.14 - 6) 2019 Modelled IHME
4.34 (3.17 - 5.81) 2018 Modelled IHME
4.28 (3.16 - 5.67) 2017 Modelled IHME
4.17 (3.18 - 5.38) 2016 Modelled IHME
4.03 (3.12 - 5.11) 2015 Modelled IHME
3.94 (3.12 - 4.96) 2014 Modelled IHME
3.81 (3.01 - 4.76) 2013 Modelled IHME
3.84 (3.05 - 4.76) 2012 Modelled IHME
3.81 (2.95 - 4.80) 2011 Modelled IHME
3.76 (2.98 - 4.67) 2010 Modelled IHME
3.72 (2.98 - 4.65) 2009 Modelled IHME
3.62 (2.90 - 4.52) 2008 Modelled IHME
3.5 (2.81 - 4.34) 2007 Modelled IHME
3.46 (2.77 - 4.29) 2006 Modelled IHME
3.42 (2.75 - 4.26) 2005 Modelled IHME
3.41 (2.73 - 4.25) 2004 Modelled IHME
3.43 (2.73 - 4.26) 2003 Modelled IHME
3.39 (2.69 - 4.21) 2002 Modelled IHME
3.37 (2.68 - 4.21) 2001 Modelled IHME
3.37 (2.68 - 4.23) 2000 Modelled IHME
3.46 (2.72 - 4.37) 1999 Modelled IHME
3.18 (2.49 - 3.97) 1998 Modelled IHME
3.16 (2.47 - 3.93) 1997 Modelled IHME
3.13 (2.43 - 3.91) 1996 Modelled IHME
3.13 (2.43 - 3.96) 1995 Modelled IHME
2.97 (2.30 - 3.77) 1994 Modelled IHME
2.82 (2.17 - 3.61) 1993 Modelled IHME
2.71 (2.09 - 3.45) 1992 Modelled IHME
2.62 (2.02 - 3.34) 1991 Modelled IHME
2.55 (1.97 - 3.24) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,388 (983 - 1,877) 2019 Modelled IHME
1,344 (980 - 1,799) 2018 Modelled IHME
1,308 (965 - 1,734) 2017 Modelled IHME
1,261 (962 - 1,626) 2016 Modelled IHME
1,206 (932 - 1,528) 2015 Modelled IHME
1,167 (921 - 1,466) 2014 Modelled IHME
1,114 (881 - 1,392) 2013 Modelled IHME
1,107 (881 - 1,373) 2012 Modelled IHME
1,086 (840 - 1,368) 2011 Modelled IHME
1,058 (840 - 1,316) 2010 Modelled IHME
1,034 (827 - 1,293) 2009 Modelled IHME
991 (795 - 1,240) 2008 Modelled IHME
946 (759 - 1,172) 2007 Modelled IHME
922 (738 - 1,143) 2006 Modelled IHME
897 (721 - 1,117) 2005 Modelled IHME
881 (706 - 1,098) 2004 Modelled IHME
869 (692 - 1,081) 2003 Modelled IHME
844 (670 - 1,047) 2002 Modelled IHME
822 (654 - 1,027) 2001 Modelled IHME
804 (639 - 1,008) 2000 Modelled IHME
803 (632 - 1,014) 1999 Modelled IHME
719 (562 - 898) 1998 Modelled IHME
694 (543 - 864) 1997 Modelled IHME
667 (519 - 835) 1996 Modelled IHME
647 (503 - 819) 1995 Modelled IHME
595 (461 - 756) 1994 Modelled IHME
547 (422 - 700) 1993 Modelled IHME
509 (392 - 649) 1992 Modelled IHME
477 (368 - 608) 1991 Modelled IHME
450 (347 - 572) 1990 Modelled IHME
428 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
16 (11 - 22) 2019 Modelled IHME
16 (11 - 22) 2018 Modelled IHME
16 (11 - 22) 2017 Modelled IHME
16 (11 - 22) 2016 Modelled IHME
16 (11 - 22) 2015 Modelled IHME
16 (11 - 22) 2014 Modelled IHME
16 (11 - 22) 2013 Modelled IHME
16 (11 - 22) 2012 Modelled IHME
16 (11 - 21) 2011 Modelled IHME
16 (11 - 21) 2010 Modelled IHME
16 (11 - 22) 2009 Modelled IHME
16 (11 - 22) 2008 Modelled IHME
16 (11 - 22) 2007 Modelled IHME
16 (11 - 22) 2006 Modelled IHME
16 (11 - 22) 2005 Modelled IHME
16 (11 - 22) 2004 Modelled IHME
16 (11 - 22) 2003 Modelled IHME
17 (11 - 22) 2002 Modelled IHME
16 (11 - 22) 2001 Modelled IHME
16 (11 - 22) 2000 Modelled IHME
16 (11 - 22) 1999 Modelled IHME
16 (11 - 22) 1998 Modelled IHME
16 (11 - 22) 1997 Modelled IHME
16 (11 - 22) 1996 Modelled IHME
16 (11 - 23) 1995 Modelled IHME
16 (11 - 23) 1994 Modelled IHME
16 (11 - 22) 1993 Modelled IHME
16 (11 - 22) 1992 Modelled IHME
16 (11 - 22) 1991 Modelled IHME
16 (11 - 22) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women, Risk-based
HepB birth dose policy
Yes
Year of birth dose introduction
1989
Eligible for HBV generic medicines
No
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
3,001
2019
(2,297 - 3,869)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,388
2019
(983 - 1,877)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
95 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
No